The search for effective drugs to treat schizophrenia is complicated by the fact that the disorder is complex and involves multiple neurotransmitters (brain chemicals). The endocannabinoid system is one of the systems which is altered in this disease.
In this double-blind study the effects of the cannabis (marijuana) component, cannabidiol, was compared to
amisulpride—one of the most effective drugs currently in use for the treatment of schizophrenia.
The results showed that cannabidiol was an equally effective treatment as the drug. Not only did it work as well, but cannabidiol actually had less negative side effects than the drug.
